Literature DB >> 16713188

Cytoskeleton reassembly in cardiomyocytes infected by Trypanosoma cruzi is triggered by treatment with ergosterol biosynthesis inhibitors.

Dayse T Silva1, Maria de Nazareth S L de Meirelles, Danielle Almeida, Julio A Urbina, Mirian Claudia S Pereira.   

Abstract

We have previously shown that Trypanosoma cruzi-infected cardiomyocytes present alterations in cytoskeletal organisation in vitro. The remarkable change in the host cell cytoskeleton opened up the question of whether treatment of infected cells with antitrypanosomal compounds, such as ergosterol biosynthesis inhibitors (EBIs), allows the reconstruction of myofibrils and the microtubule network, restoring the cell biological function. Therefore, 48-h-old T. cruzi-infected cardiomyocyte cultures were treated with 10 nM ketoconazole or posaconazole and cytoskeletal remodelling of the host cells was analysed by indirect immunofluorescence assay. Both compounds displayed a potent antiparasitic effect and dramatically reduced the infection ratio. After 120 h of treatment, actin polygonal configuration was frequently visualised in the host cell cytoplasm, suggesting the initial stage of actin framework restoration. Rearrangement of myofibrils and the microtubule network was achieved 168 h after the start of drug treatment. Our data demonstrate that the trypanocidal effect of EBIs lead to reconstruction of the cytoskeleton of T. cruzi-infected cardiomyocytes in vitro.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16713188     DOI: 10.1016/j.ijantimicag.2005.12.012

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  8 in total

1.  Chagas disease: pushing through the pipeline.

Authors:  Julie Clayton
Journal:  Nature       Date:  2010-06-24       Impact factor: 49.962

2.  Amiodarone inhibits Trypanosoma cruzi infection and promotes cardiac cell recovery with gap junction and cytoskeleton reassembly in vitro.

Authors:  Daniel Adesse; Eduardo Meirelles Azzam; Maria de Nazareth L Meirelles; Julio A Urbina; Luciana R Garzoni
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  Trypanosoma cruzi infection induces a global host cell response in cardiomyocytes.

Authors:  Patricio A Manque; Christian M Probst; Christian Probst; Mirian C S Pereira; Rita C P Rampazzo; Luiz Shozo Ozaki; L Shozo Ozaki; Daniela P Pavoni; Dayse T Silva Neto; M Ruth Carvalho; Ping Xu; Myrna G Serrano; João M P Alves; Maria de Nazareth S L Meirelles; Samuel Goldenberg; Marco A Krieger; Gregory A Buck
Journal:  Infect Immun       Date:  2011-02-22       Impact factor: 3.441

4.  Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in Trypanosoma cruzi-infected cardiac cells.

Authors:  Juliana Magalhães Chaves Barbosa; Yasmin Pedra-Rezende; Luíza Dantas Pereira; Tatiana Galvão de Melo; Helene Santos Barbosa; Joseli Lannes-Vieira; Solange Lisboa de Castro; Anissa Daliry; Kelly Salomão
Journal:  Front Cell Infect Microbiol       Date:  2022-08-25       Impact factor: 6.073

5.  Current understanding of the Trypanosoma cruzi-cardiomyocyte interaction.

Authors:  Claudia M Calvet; Tatiana G Melo; Luciana R Garzoni; Francisco O R Oliveira; Dayse T Silva Neto; Maria N S L; L Meirelles; Mirian C S Pereira
Journal:  Front Immunol       Date:  2012-10-30       Impact factor: 7.561

6.  Genetic profiling of the isoprenoid and sterol biosynthesis pathway genes of Trypanosoma cruzi.

Authors:  Raúl O Cosentino; Fernán Agüero
Journal:  PLoS One       Date:  2014-05-14       Impact factor: 3.240

Review 7.  Synthetic Medicinal Chemistry in Chagas' Disease: Compounds at The Final Stage of "Hit-To-Lead" Phase.

Authors:  Hugo Cerecetto; Mercedes González
Journal:  Pharmaceuticals (Basel)       Date:  2010-03-25

8.  Long term follow-up of Trypanosoma cruzi infection and Chagas disease manifestations in mice treated with benznidazole or posaconazole.

Authors:  Claudia Magalhães Calvet; Tatiana Araújo Silva; Diane Thomas; Brian Suzuki; Ken Hirata; Jair Lage Siqueira-Neto; James H McKerrow
Journal:  PLoS Negl Trop Dis       Date:  2020-09-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.